Joris J Komen (Joris Komen)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Acute Coronary Syndrome

Antiplatelet Therapy

Oral Anticoagulants

Atrial Fibrillation

Top Venues

Pharmacoepidemiology and drug safety

European heart journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Maja Hellfritzsch, Nina Sahlertz Kristiansen, Morten Olesen, Marion Bennie, Tanja Mueller, Annemarie Voss, Tania Schink, Ulrike Haug, Bianca Kollhorst, Øystein Karlstad, Lars J Kjerpeseth, Olaf H Klungel
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 23 (11) (2022)
Joris J Komen, Tomas Forslund, Aukje K Mantel-Teeuwisse, Olaf H Klungel, Mia von Euler, Frieder Braunschweig, Håkan Wallén, Paul Hjemdahl
Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021. European heart journal. Cardiovascular pharmacotherapy 7 (3) (2022)
Joris J Komen, Jesper Hallas, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Nina Sahlertz Kristiansen, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H Klungel
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. European heart journal 43 (37) (2022)
Joris J Komen, Anton Pottegård, Paul Hjemdahl, Aukje K Mantel-Teeuwisse, Björn Wettermark, Maja Hellfritzsch, J Hallas, Ron Herings, Lisa Smits, Thomas Forslund, Olaf Klungel
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds. Heart (British Cardiac Society) (2021)
Joris J Komen, Svetlana V Belitser, Richard Wyss, Sebastian Schneeweiss, Anne C Taams, Romin Pajouheshnia, Tomas Forslund, Olaf H Klungel
Greedy caliper propensity score matching can yield variable estimates of the treatment-outcome association-A simulation study. Pharmacoepidemiology and drug safety 30 (7) (2021)
Fatma Rustem Gulluoglu, Patrick C Souverein, Hendrika A van den Ham, Anthonius de Boer, Joris J Komen
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study. Pharmacoepidemiology and drug safety 30 (10) (2020)
Joris J Komen, Tomas Forslund, Paul Hjemdahl, Björn Wettermark
Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs. European journal of clinical pharmacology 73 (10) (2017)